Wall Street Zen Upgrades Nukkleus (NASDAQ:DFNS) to Sell

Nukkleus (NASDAQ:DFNS) was upgraded by investment analysts at Wall Street Zen from a “strong sell” rating to a “sell” rating in a research report issued to clients and investors on Sunday.

DFNS has been the topic of a number of other reports. Noble Financial upgraded Nukkleus to a “strong-buy” rating in a research report on Monday, June 29th. Weiss Ratings cut Nukkleus from a “sell (d+)” rating to a “sell (e+)” rating in a research report on Monday, July 20th. One equities research analyst has rated the stock with a Strong Buy rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy”.

Nukkleus Trading Down 46.6%

Shares of Nukkleus stock opened at $11.01 on Friday. Nukkleus has a 12-month low of $3.70 and a 12-month high of $1,948.75. The company has a current ratio of 0.14, a quick ratio of 0.11 and a debt-to-equity ratio of 0.07. The stock has a market cap of $11.12 million, a PE ratio of -0.03 and a beta of -5.80. The company has a 50-day moving average of $24.68 and a two-hundred day moving average of $87.14.

Nukkleus (NASDAQ:DFNS) last announced its quarterly earnings results on Wednesday, August 19th. The company reported ($173.80) EPS for the quarter, missing the consensus estimate of ($3.11) by ($170.69). The firm had revenue of $4.00 million during the quarter, compared to analyst estimates of $4.50 million. On average, research analysts anticipate that Nukkleus will post -4.21 EPS for the current fiscal year.

Institutional Trading of Nukkleus

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in DFNS. BNP Paribas Financial Markets acquired a new position in Nukkleus in the 2nd quarter valued at about $56,000. State Street Corp grew its holdings in shares of Nukkleus by 70.7% during the fourth quarter. State Street Corp now owns 17,863 shares of the company’s stock worth $72,000 after buying an additional 7,400 shares in the last quarter. Price T Rowe Associates Inc. MD purchased a new stake in shares of Nukkleus during the fourth quarter worth about $57,000. GM Advisory Group LLC acquired a new position in shares of Nukkleus in the fourth quarter valued at approximately $56,000. Finally, Millennium Management LLC acquired a new position in shares of Nukkleus in the fourth quarter valued at approximately $60,000. Hedge funds and other institutional investors own 12.47% of the company’s stock.

About Nukkleus

Nukkleus Inc, a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors. In addition, the company provides software, technology, customer sales and marketing, and risk management technology hardware and software solutions.